All Stories

  1. Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation
  2. Less dementia with oral anticoagulation in atrial fibrillation
  3. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries
  4. OUTCOME IN RELATION TO ANTITHROMBOTIC THERAPY AFTER MYOCARDIAL INFARCTION AND PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
  5. ANTITHROMBOTIC MEDICATION AND OUTCOMES AFTER MYOCARDIAL INFARCTION IN PATIENTS WITH ATRIAL FIBRILLATION NOT UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
  6. Benefit of Anticoagulation Unlikely in Patients With Atrial Fibrillation and a CHA2DS2-VASc Score of 1
  7. Association Between Use of β-Blockers and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction
  8. Response to Letter Regarding Article, "High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke"
  9. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke
  10. Adherence to warfarin treatment among patients with atrial fibrillation
  11. High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke
  12. Safety of Dronedarone in Routine Clinical Care
  13. Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study
  14. The Cost-Effectiveness of Screening for Silent Atrial Fibrillation After Ischaemic Stroke
  15. Atrial fibrillation patients do not benefit from acetylsalicylic acid
  16. Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited: A Population-Based Study
  17. Atrial fibrillation prevalence revisited
  18. Mass screening for silent atrial fibrillation in high risk patients - preliminary results from the STROKESTOP trial
  19. Response to Letter Regarding Article, "Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study"
  20. Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)
  21. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
  22. Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study
  23. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
  24. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events
  25. Cardiovascular hospitalization as a surrogate endpoint for mortality in studies of atrial fibrillation: report from the Stockholm Cohort Study of Atrial Fibrillation
  26. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF)
  27. The prognosis of patients with atrial fibrillation is improved when sinus rhythm is restored: report from the Stockholm Cohort of Atrial Fibrillation (SCAF)
  28. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation
  29. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)
  30. Stroke prophylaxis in patients with atrial fibrillation: what can we do about it?: reply
  31. Stroke prophylaxis in atrial fibrillation: who gets it and who does not?
  32. Rapid Down-regulation of Thyroid Hormones in Acute Myocardial Infarction
  33. Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction